GlassScriptPhysician profile
David A Torres
NPI 1295198802
$2,610.70
in general payments reported to CMS, 2019-2025
10 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $207 · 2021: $592 · 2022: $510 · 2023: $231 · 2024: $565 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $990.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $1,478.36 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $470.66 | 2019-2021 | |
| Boston Scientific Corporation | $168.63 | 2023 | Watchman Flx, Watchman Access System |
| Astrazeneca Pharmaceuticals LP | $121.84 | 2024 | Andexxa |
| Smith+Nephew, INC. | $79.08 | 2022-2023 | Grafix Pl, Stravix |
| Janssen Pharmaceuticals, INC | $77.31 | 2021-2024 | Xarelto |
| Pfizer INC. | $63.21 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55.97 | 2021-2023 | |
| E.R. Squibb & Sons, L.L.C. | $54.38 | 2019-2020 | |
| Abbvie INC. | $41.26 | 2023-2024 | Dalvance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.